Hydrocodone Bitartrate And Homatropine Methylbromide Interactions

7 DRUG INTERACTIONS No specific drug interaction studies have been conducted with hydrocodone bitartrate and homatropine methylbromide. (5.9, 7.9) 7.1 Alcohol Concomitant use of alcohol with hydrocodone bitartrate and homatropine methylbromide can result in an increase of hydrocodone plasma levels and potentially fatal overdose of hydrocodone. Instruct patients not to consume alcoholic beverages or use prescription or nonprescription products containing alcohol while on hydrocodone bitartrate and homatropine methylbromide therapy [see Warnings and Precautions (5.8), Clinical Pharmacology (12.3)] .

Source: FDA drug label - hydrocodone bitartrate and homatropine methylbromide

7.2 Inhibitors of CYP3A4 and CYP2D6 The concomitant use of hydrocodone bitartrate and homatropine methylbromide and CYP3A4 inhibitors, such as macrolide antibiotics (e.g., erythromycin), azole-antifungal agents (e.g.

Source: FDA drug label - hydrocodone bitartrate and homatropine methylbromide

7 DRUG INTERACTIONS No specific drug interaction studies have been conducted with hydrocodone bitartrate and homatropine methylbromide. (7.5) Monoamine Oxidase Inhibitors (MAOIs) : Can potentiate the effects of hydrocodone. (7.7) Diuretics : Hydrocodone may reduce the efficacy of diuretics.

Source: FDA drug label - hydrocodone bitartrate and homatropine methylbromide

ketoconazole), or protease inhibitors (e.g., ritonavir), can increase the plasma concentration of hydrocodone, resulting in increased or prolonged opioid effects.

Source: FDA drug label - hydrocodone bitartrate and homatropine methylbromide

ketoconazole), or protease inhibitors (e.g., ritonavir), can increase the plasma concentration of hydrocodone, resulting in increased or prolonged opioid effects.

Source: FDA drug label - hydrocodone bitartrate and homatropine methylbromide